KR20230066660A - 치주염 백신 및 관련 조성물 및 사용 방법 - Google Patents

치주염 백신 및 관련 조성물 및 사용 방법 Download PDF

Info

Publication number
KR20230066660A
KR20230066660A KR1020237015301A KR20237015301A KR20230066660A KR 20230066660 A KR20230066660 A KR 20230066660A KR 1020237015301 A KR1020237015301 A KR 1020237015301A KR 20237015301 A KR20237015301 A KR 20237015301A KR 20230066660 A KR20230066660 A KR 20230066660A
Authority
KR
South Korea
Prior art keywords
sequence
amino acid
acid sequence
antigen
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020237015301A
Other languages
English (en)
Korean (ko)
Inventor
제프리 페어맨
Original Assignee
박사이트, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박사이트, 인코포레이티드 filed Critical 박사이트, 인코포레이티드
Publication of KR20230066660A publication Critical patent/KR20230066660A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0216Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1020237015301A 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법 Ceased KR20230066660A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762571582P 2017-10-12 2017-10-12
US62/571,582 2017-10-12
KR1020207013299A KR102530966B1 (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법
PCT/US2018/055496 WO2019075260A1 (en) 2017-10-12 2018-10-11 VACCINE AGAINST PERIODONTITIS AND ASSOCIATED COMPOSITIONS AND METHOD OF USE

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020207013299A Division KR102530966B1 (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법

Publications (1)

Publication Number Publication Date
KR20230066660A true KR20230066660A (ko) 2023-05-16

Family

ID=64110091

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020237015301A Ceased KR20230066660A (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법
KR1020207013299A Active KR102530966B1 (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020207013299A Active KR102530966B1 (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법

Country Status (14)

Country Link
US (3) US10835590B2 (https=)
EP (1) EP3694547A1 (https=)
JP (2) JP7258870B2 (https=)
KR (2) KR20230066660A (https=)
CN (1) CN111225684A (https=)
AU (1) AU2018347511A1 (https=)
CA (1) CA3078630A1 (https=)
EA (1) EA202090908A1 (https=)
IL (1) IL273690A (https=)
MA (1) MA50363A (https=)
MX (1) MX2020003810A (https=)
PH (1) PH12020550239A1 (https=)
SG (1) SG11202003147XA (https=)
WO (1) WO2019075260A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202003147XA (en) * 2017-10-12 2020-05-28 Vaxcyte Inc Periodontitis vaccine and related compositions and method of use
WO2025019900A1 (en) * 2023-07-26 2025-01-30 Denteric Pty Ltd Chimeric protein vaccine
CN116751292B (zh) * 2023-07-31 2024-05-14 河南大学 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59128338A (ja) 1982-12-08 1984-07-24 Kitasato Inst:The 歯周炎予防用ワクチン及びその製法
WO1994028014A2 (en) 1993-05-28 1994-12-08 Chiron Corporation Peptide inhibitors of urokinase receptor activity
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
CA2249994A1 (en) * 1996-03-22 1997-09-25 University Of Georgia Research Foundation, Inc. Immunogenic compositions comprising porphyromonas gingivalis peptides and methods
US6833262B1 (en) 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
AUPQ065299A0 (en) 1999-05-28 1999-06-24 University Of Sydney, The A method of prophylaxis and treatment and agents useful for same
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
US7378101B2 (en) 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
GB0411150D0 (en) 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
CN102712693A (zh) 2009-08-02 2012-10-03 圣诺菲·帕斯图尔有限公司 牙龈卟啉单胞菌多肽
WO2011097688A1 (en) 2010-02-12 2011-08-18 The University Of Sydney Protein domains and uses therefor
US9040253B2 (en) 2010-04-14 2015-05-26 Sutro Biopharma, Inc. Method for enhancing recombinant protein production by cell-free protein expression system
PL2906592T3 (pl) 2012-10-12 2019-07-31 Sutro Biopharma, Inc. Proteolityczna inaktywacja wybranych białek w ekstraktach bakteryjnych dla ulepszonej ekspresji
EP3365027B1 (en) * 2015-10-14 2022-03-30 Research Institute at Nationwide Children's Hospital Hu specific antibodies and their use in inhibiting biofilm
SG11202003147XA (en) 2017-10-12 2020-05-28 Vaxcyte Inc Periodontitis vaccine and related compositions and method of use

Also Published As

Publication number Publication date
US20240226259A9 (en) 2024-07-11
US20210361756A1 (en) 2021-11-25
US20190192645A1 (en) 2019-06-27
US10835590B2 (en) 2020-11-17
PH12020550239A1 (en) 2021-02-15
US12121575B2 (en) 2024-10-22
BR112020006500A2 (pt) 2020-10-13
US11701414B2 (en) 2023-07-18
AU2018347511A1 (en) 2020-05-21
US20240131134A1 (en) 2024-04-25
JP2020536925A (ja) 2020-12-17
SG11202003147XA (en) 2020-05-28
WO2019075260A1 (en) 2019-04-18
CA3078630A1 (en) 2019-04-18
KR20200070302A (ko) 2020-06-17
CN111225684A (zh) 2020-06-02
MX2020003810A (es) 2020-08-13
JP2023098935A (ja) 2023-07-11
EA202090908A1 (ru) 2020-10-29
MA50363A (fr) 2020-08-19
AU2018347511A8 (en) 2020-06-11
KR102530966B1 (ko) 2023-05-15
JP7258870B2 (ja) 2023-04-17
IL273690A (en) 2020-05-31
EP3694547A1 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
US12121575B2 (en) Periodontitis vaccine and related compositions and methods of use
US10947280B2 (en) UspA2 protein constructs and uses thereof
KR101721904B1 (ko) P.진지발리스 감염의 예방, 치료 및 진단
JP5627581B2 (ja) ソマトスタチン免疫原性増進のための組成物および方法
JP7847091B2 (ja) 肺炎桿菌o抗原ワクチン
EP4466013A1 (en) Chimeric polypeptides
WO2023137519A1 (en) Chimeric polypeptides
WO2023137521A1 (en) Chimeric polypeptides
KR20210146392A (ko) 침습 플라스미드 항원 b의 최적화된 무세포 합성 및 관련 조성물 및 사용 방법
EA044863B1 (ru) Вакцина и связанные композиции для лечения пародонтита и способ применения
BR112020006500B1 (pt) Composição imunogênica e seus usos, formulação de vacina e usos de um polipeptídeo para fabricação de uma composição imunogênica
CN102772792B (zh) 一种预防龋齿的疫苗及其制备方法
EA050190B1 (ru) Оптимизированный бесклеточный синтез плазмидного антигена инвазии в и родственные композиции и способы применения
KR20160049875A (ko) 플라젤린 및 치주 질환 유발 병원체의 단백질을 포함하는 재조합 융합 단백질 및 이의 용도

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20230504

Application number text: 1020207013299

Filing date: 20200508

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240513

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20250514

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D